Board committee change

GlaxoSmithKline PLC 25 May 2005 Issued - Wednesday 25th May 2005, London - LSE Announcement GlaxoSmithKline plc Announces Change to the Board's Remuneration Committee The Board has appointed Dr Ronaldo Schmitz a member of the Remuneration Committee, with immediate effect. This brings the membership of the Committee to four Non-Executive Directors all of whom are independent The attached list shows the membership of the Board's Committees. S M Bicknell Company Secretary 25th May 2005 Board Committee Membership with effect from 25th May 2005. Board Committee Committee Chairman Members Audit Dr Ronaldo Schmitz Sir Deryck Maughan Sir Ian Prosser Sir Robert Wilson Remuneration Sir Robert Wilson Mr H Lawrence Culp Sir Crispin Davis Dr Ronaldo Schmitz Nominations Sir Christopher Gent Sir Ian Prosser Dr Ronaldo Schmitz Corporate Responsibility Sir Christopher Gent Sir Ian Prosser Dr Lucy Shapiro GSK Enquiries: UK Media enquiries: Philip Thomson (020) 8047 5502 David Mawdsley (020) 8047 5502 Chris Hunter-Ward (020) 8047 5502 Alice Hunt (020) 8047 5502 US Media enquiries: Nancy Pekarek (215) 751 7709 Mary Anne Rhyne (919) 483 2839 Patricia Seif (215) 751 7709 European Analyst/Investor enquiries: Duncan Learmouth (020) 8047 5540 Anita Kidgell (020) 8047 5542 Jen Hill (020) 8047 5543 US Analyst/ Investor enquiries: Frank Murdolo (215) 751 7002 Tom Curry (215) 751 5419 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100